Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

AAM. 2022; 11(1): 104-109


Prayogika Dhumapana as a palliative approach in de-addiction towards tobacco smokers -hype or hope?

Chinmay Bhalchandra Tendulkar, Arati Abhay Shinde.




Abstract

Tobacco consumption in all forms including passive smoking is a major cause of preventable death, and this was highlighted in a report of 2019 by World Health Organization (WHO). Tobacco is a one of the leading causative factor for around 6 million deaths per year worldwide, which is expected to shoot up to 10 million per year by 2020 or in early 2030. Quantity and duration of tobacco consumption may affect human health thereby causing diseases such as, chronic pulmonary disease, heart attacks, delayed fracture healing, hypertension, skin and eye infection and cancer. Ayurveda on the contrary has proposed numerous ways (e.g. Rasayana, Yoga) to alleviate the consequences of cigarette smoking. However, the effects of palliative care in daily regime on smoking related injuries is not yet fully discovered. This report hence, mainly highlights the constructive impact of dhumapana as a palliative care in the prolongation of the apprehensions arose due to habitual cigarette smoking. The term ‘Dhumapana’ has explained in various samhitas and hence mentioned under the title of Dinacharya, that explicate the fundamental principles aimed at preventing occurrence of health issues, thereby positively affecting doshas (humors of the body). Unlike conventional drug based approach, if dhumapana adopted in daily routine by patients, it may prolong the onset of tobacco consumption and therefore, speculated to improve the welfare.

Key words: Tobacco smokers, Palliative care, Prayogik Dhumapana, De-addiction, Padanshik karma.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.